AnaptysBio Inc (NASDAQ:ANAB) has a beta value of -0.27 and has seen 1.02 million shares traded in the last trading session. The company, currently valued at $664.97M, closed the last trade at $24.34 per share which meant it gained $3.04 on the day or 14.27% during that session. The ANAB stock price is -12.98% off its 52-week high price of $27.50 and 45.11% above the 52-week low of $13.36. The 3-month trading volume is 339.66K shares.
AnaptysBio Inc (NASDAQ:ANAB) trade information
Sporting 14.27% in the green in last session, the stock has traded in the green over the last five days, when the ANAB stock price touched $24.34 or saw a rise of 0.65%. Year-to-date, AnaptysBio Inc shares have moved 13.63%, while the 5-day performance has seen it change 26.90%. Over the past 30 days, the shares of AnaptysBio Inc (NASDAQ:ANAB) have changed 14.17%.
AnaptysBio Inc (ANAB) estimates and forecasts
Figures show that AnaptysBio Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 48.87% over the past 6 months, with this year growth rate of -1.48%, compared to 12.60% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 1.30% and -7.30% for the next quarter. Revenue growth from the last financial year stood is estimated to be -1.70%.
9 analysts offering their estimates for the company have set an average revenue estimate of $3.72 million for the current quarter. 9 have an estimated revenue figure of $4.02 million for the next quarter concluding in Jun 2024. Year-ago sales stood $3.57 million and $3.46 million respectively for this quarter and the next, and analysts expect sales will grow by 4.20% for the current quarter and 16.20% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -19.45% over the past 5 years.
ANAB Dividends
AnaptysBio Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
